Sign In
to Vote &
Create Storyboards.
 

Analyst Moves: CVS, PSX

Forbes - 14 Dec 2012 20:38
CVS Caremark (CVS) had its numbers increased by Lazard (LAZ) after the company boosted guidance. A $48.50 price target was set with a buy rating.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard